1
|
Akgül B, Tozsin A, Tokas T, Micali S, Herrmann T, Bianchi G, Fiori C, Altınkaya N, Ortner G, Knoll T, Lehrich K, Böhme A, Gadzhiev N, Omar M, Kartalas Goumas I, Romero Otero J, Aydın A, Lusuardi L, Netsch C, Khan A, Greco F, Dasgupta P, Tunc L, Rassweiler J, Serdar Gozen A, Ahmed K, Güven S. Development of a Bladder Injury Classification System for Endoscopic Procedures: A Mixed-methods Study Involving Expert Consensus and Validation. Eur Urol Focus 2024:S2405-4569(24)00171-8. [PMID: 39327217 DOI: 10.1016/j.euf.2024.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Revised: 08/06/2024] [Accepted: 09/09/2024] [Indexed: 09/28/2024]
Abstract
BACKGROUND AND OBJECTIVE The widespread adoption and rapid integration of new technologies and techniques in endoscopic and laser bladder interventions, particularly endoscopic enucleation, have led to new types of bladder injuries. This underscores the need for an intraoperative injury classification system. This study aims to develop and validate the Bladder Injury Classification System for Endoscopic Procedures (BICEP), which standardizes the classification of complications and intervention requirements. METHODS This mixed-methods study involved experts from the European Association of Urology Section of Urotechnology to standardize and validate the BICEP classification system. An iterative process involving focus groups, expert surveys, and revisions assessed clarity, relevance, comprehensiveness, and practicality. Validity was confirmed through expert surveys conducted in two rounds for face and content validity, using a 5-point Likert scale to correlate ratings with expected outcomes. KEY FINDINGS AND LIMITATIONS The novel BICEP classification system categorizes bladder injuries into ten subcategories with scores ranging from 0 to 4, reflecting injury severity and management requirements. Face validity was demonstrated by a 95% consensus on the system's clarity, relevance, and comprehensiveness. Content validity was supported by high acceptance rates in expert surveys, with average scores of 4.53 and 4.58 in the first and second rounds, respectively. This demonstrates strong support for its applicability in clinical practice. However, the primary limitation is the lack of external validation. CONCLUSIONS AND CLINICAL IMPLICATIONS Our study demonstrates that the BICEP system is a robust and comprehensive classification system, with strong support for its face and content validity. The BICEP system is a proposal based on expert opinion, and additional studies are necessary to ensure its widespread adoption and efficacy. PATIENT SUMMARY Our study addressed the critical need for standardized classification in the increasingly widespread context of urology endoscopic technologies by focusing on intraoperative evaluation, reporting, and standardization of bladder injuries. This study provides a globally standardized basis for the classification and treatment of bladder injuries in urology endoscopic procedures.
Collapse
Affiliation(s)
- Burak Akgül
- Department of Urology, Trakya University School of Medicine Hospital, Edirne, Turkey
| | - Atınc Tozsin
- Department of Urology, Trakya University School of Medicine Hospital, Edirne, Turkey
| | - Theodoros Tokas
- Department of Urology, University General Hospital of Heraklion, Athens, Greece
| | - Salvatore Micali
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy
| | - Thomas Herrmann
- Department of Urology, Kantonspital Thurgau AG Pfaffenholzstrasse, Frauenfeld, Switzerland
| | - Giampaolo Bianchi
- Department of Urology, Università degli studi di Modena e Reggio Emilia, Modena, Italy
| | - Cristian Fiori
- Department of Oncology, University of Turin, Turin, Italy
| | - Nurullah Altınkaya
- Department of Urology, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey
| | - Gernot Ortner
- Department of Urology, General Hospital Hall I.T, Tirol, Austria
| | - Thomas Knoll
- Klinikum Sindelfingen-Boeblingen, Sindelfingen, Germany
| | - Karin Lehrich
- Department of Urology, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany
| | - Axel Böhme
- Department of Urology, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany
| | - Nariman Gadzhiev
- Saint-Petersburg State University Hospital, St. Petersburg, Russia
| | - Mohamed Omar
- Department of Urology, Menoufiya University Hospital, Menoufiya, Egypt
| | | | - Javier Romero Otero
- Department of Urology, ROC Clinic and Fundación Investigación HM Hospitales, Madrid, Spain
| | - Abdullatif Aydın
- Faculty of Life Sciences and Medicine, King's College London, Guy's and St. Thomas' NHS Foundation Trust, King's Health Partners, London, UK
| | - Lukas Lusuardi
- Department of Urology, Paracelsus Medical University Salzburg University Hospital, Salzburg, Austria
| | | | - Azhar Khan
- Faculty of Life Sciences and Medicine, King's College London, Guy's and St. Thomas' NHS Foundation Trust, King's Health Partners, London, UK
| | - Francesco Greco
- U.O.C. Chirurgia Endocrina e Metabolica, Centro Dipartimentale di Chirurgia Endocrina e dell'Obesità, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
| | - Prokar Dasgupta
- Faculty of Life Sciences and Medicine, King's College London, Guy's and St. Thomas' NHS Foundation Trust, King's Health Partners, London, UK
| | - Lütfi Tunc
- Department of Urology, Acıbadem Hospital, Ankara, Turkey
| | - Jans Rassweiler
- Department of Urology and Andrology, Danube Private University, Krems, Austria
| | | | - Kamran Ahmed
- Faculty of Life Sciences and Medicine, King's College London, Guy's and St. Thomas' NHS Foundation Trust, King's Health Partners, London, UK; Sheikh Khalifa Medical City, Abu Dhabi, UAE; Khalifa University, Abu Dhabi, UAE
| | - Selçuk Güven
- Department of Urology, Necmettin Erbakan University Meram School of Medicine, Konya, Turkey.
| |
Collapse
|
2
|
Pagonis K, Katsakiori P, Peteinaris A, Tatanis V, Tsaturyan A, Faria Costa G, Faitatziadis S, Vagionis A, Natsos A, Gkeka K, Obaidat M, Spinos T, Vrettos T, Liatsikos E, Kallidonis P. High-power Holmium:Yag lithotripsy in bladder urolithiasis: Is it safe and effective? A combined clinical and experimental study. Arab J Urol 2024; 22:145-151. [PMID: 38818258 PMCID: PMC11136465 DOI: 10.1080/20905998.2024.2304516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2023] [Accepted: 01/06/2024] [Indexed: 06/01/2024] Open
Abstract
Objective To evaluate the efficacy and safety of Holmium: Yttrium-Aluminum-Garnet (Ho:YAG) laser in bladder lithotripsy using high-power settings > 100 W. Materials and Methods A combined experimental and clinical study was conducted. The Quanta Cyber: Ho 150 with a 550 μm Quanta optical fiber was utilized in all set-ups. Ablation rates for soft and hard artificial stones were tested in vitro using 100 W and 20 W power settings. In the experiment, a porcine bladder was used. The optical fiber was inserted through a rigid cystoscope, whilst a K-type thermocouple was inserted in the bladder dome. The tested high-power settings were 152 W, 120 W and 105 W. In every trial, the lasing time was over 60 s. In the clinical study, 35 patients underwent transurethral high-power bladder lithotripsy. Laser settings were set between 100 W and 150 W. Results Stone mass (stone weight) was significantly lower after stone ablation independently of the stone type or the laser settings. Significantly higher mass decrease and ablation rate were detected in high-power compared to low-power settings. In the experiment, the highest temperature recorded was 32°C at 152 W. At 120 W and 105 W, the peak temperatures didn't reach 30°C. In the clinical study, a stone-free rate of 100% and a mean operative time of 43 ± 18 min were reported. All patients stayed in the hospital for one day except for one who presented minor hematuria. Additional complications did not occur. Conclusion Ho:YAG laser lithotripsy > 100 W is an effective, fast and safe modality for the treatment of bladder calculi.
Collapse
Affiliation(s)
| | | | | | | | - Arman Tsaturyan
- Department of Urology, Erebouni Medical Center, Yerevan, Armenia
| | - Gabriel Faria Costa
- Department of Urology, Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal
- Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Porto, Portugal
| | | | | | | | | | | | | | - Theofanis Vrettos
- Department of Anesthesiology and ICU, University of Patras, Patras, Greece
| | - Evangelos Liatsikos
- Department of Urology, University of Patras, Patras, Greece
- Department of Urology, Medical University of Vienna, Vienna, Austria
| | | |
Collapse
|
3
|
Chapelle C, Lavallée E, Vallée M, Descazeaud A. Bicentric retrospective study comparing the postoperative outcomes of patients treated surgically for bladder stones with or without concomitant surgery for BPH. World J Urol 2024; 42:13. [PMID: 38189811 DOI: 10.1007/s00345-023-04699-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Accepted: 10/10/2023] [Indexed: 01/09/2024] Open
Abstract
PURPOSE To compare the postoperative outcomes of male patients who underwent bladder stone (BS) removal, with or without concomitant benign prostatic hyperplasia (BPH) surgery. PATIENTS AND METHODS All men aged > 50 years who underwent BS removal at two French university hospitals between 2009 and 2018 were retrospectively reviewed. Four binary outcome criteria were identified during the follow-up: early postoperative complications, stone recurrence, subsequent surgery for BS or BPH, and late surgical complications. A composite score ranging from 0 to 4 was calculated by combining the four criteria. RESULTS A median follow-up period of 42 months was observed in 179 patients. Of these, 107 patients were in the "concomitant surgical treatment" (CST) group and 72 in the bladder "stone removal alone" (SRA) group. The CST group presented higher baseline post-void residual volume (105 vs. 30 ml, p = 0.005). Patients who underwent CST had a significantly lower rate of BS recurrence (12% vs. 39%; p = 0,001) and underwent fewer subsequent surgeries (14% vs. 44%; p < 0.001). There was no significant difference in the early (51% vs. 35%, p = 0,168) and late (26% vs. 17%, p = 0,229) complications rates between the two groups. A better composite score was observed in the CST than in the SRA, but the difference was not significant (3.07 vs. 2.72, p = 0.078). CONCLUSION As CST increases morbidity and decreases the risk of reoperation, each situation should be considered, taking into account patient choice and comorbidities.
Collapse
Affiliation(s)
- Caroline Chapelle
- CHU La Milétrie, Service d'Urologie Et de Transplantations Rénales, CHU de Poitiers, 2 Rue de La Milétrie, 86021, Poitiers, France.
| | - Etienne Lavallée
- Service de Chirurgie Urologique CHU de Québec - Hôtel-Dieu de Québec, 11 Côte du Palais, Québec, QC, G1R 2J6, Canada
| | - Maxime Vallée
- CHU La Milétrie, Service d'Urologie Et de Transplantations Rénales, CHU de Poitiers, 2 Rue de La Milétrie, 86021, Poitiers, France
| | - Aurélien Descazeaud
- Service de Chirurgie Urologique, CHU de Limoges, 2, Avenue Martin-Luther-King, 87042, Limoges, France
| |
Collapse
|
4
|
Puliyath N, Venugopalan AV, Das Kv S, Parol S. The thermal effect of lasers in urology: a review article. Lasers Med Sci 2023; 39:6. [PMID: 38093121 DOI: 10.1007/s10103-023-03948-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Accepted: 12/05/2023] [Indexed: 12/18/2023]
Abstract
Lasers as a technology have a leading role in the modern urological treatment armamentarium. In this article, the application of lasers in different areas of urology is described. The major uses are in urolithiasis, benign prostatic enlargement (BPE), and management of many urological malignancies and other benign pathologies. Lasers have become an established treatment modality in urolithiasis, an acceptable alternative with the least side effect profile in BPE patients, and a novel and promising therapy in many other fields of Urology.
Collapse
Affiliation(s)
- Nisanth Puliyath
- Department of Urology & Renal Transplant Surgery, Government Medical College, Kozhikode, India.
| | - A V Venugopalan
- Department of Urology & Renal Transplant Surgery, Government Medical College, Kozhikode, India
| | - Shanmugha Das Kv
- Department of Urology & Renal Transplant Surgery, Government Medical College, Kozhikode, India
| | - Subeesh Parol
- Department of Urology & Renal Transplant Surgery, Government Medical College, Kozhikode, India
| |
Collapse
|
5
|
Vafa E, Tayebi L, Abbasi M, Azizli MJ, Bazargan-Lari R, Talaiekhozani A, Zareshahrabadi Z, Vaez A, Amani AM, Kamyab H, Chelliapan S. A better roadmap for designing novel bioactive glasses: effective approaches for the development of innovative revolutionary bioglasses for future biomedical applications. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2023; 30:116960-116983. [PMID: 36456674 DOI: 10.1007/s11356-022-24176-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/27/2022] [Accepted: 11/08/2022] [Indexed: 06/17/2023]
Abstract
The introduction of bioactive glasses (BGs) precipitated a paradigm shift in the medical industry and opened the path for the development of contemporary regenerative medicine driven by biomaterials. This composition can bond to live bone and can induce osteogenesis by the release of physiologically active ions. 45S5 BG products have been transplanted effectively into millions of patients around the world, primarily to repair bone and dental defects. Over the years, many other BG compositions have been introduced as innovative biomaterials for repairing soft tissue and delivering drugs. When research first started, many of the accomplishments that have been made today were unimaginable. It appears that the true capacity of BGs has not yet been realized. Because of this, research involving BGs is extremely fascinating. However, to be successful, it requires interdisciplinary cooperation between physicians, glass chemists, and bioengineers. The present paper gives a picture of the existing clinical uses of BGs and illustrates key difficulties deserving to be faced in the future. The challenges range from the potential for BGs to be used in a wide variety of applications. We have high hopes that this paper will be of use to both novice researchers, who are just beginning their journey into the world of BGs, as well as seasoned scientists, in that it will promote conversation regarding potential additional investigation and lead to the discovery of innovative medical applications for BGs.
Collapse
Affiliation(s)
- Ehsan Vafa
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Lobat Tayebi
- Marquette University School of Dentistry, Milwaukee, WI, USA
| | - Milad Abbasi
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mohammad Javad Azizli
- Department of Chemistry and Chemical Engineering, Islamic Azad University, Rasht, Rasht Branch, Iran
| | - Reza Bazargan-Lari
- Department of Materials Science and Engineering, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran
| | - Amirreza Talaiekhozani
- Department of Civil Engineering, Jami Institute of Technology, Isfahan, Iran
- Alavi Educational and Cultural Complex, Shiraz, Iran
| | - Zahra Zareshahrabadi
- Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Ahmad Vaez
- Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
| | - Ali Mohamad Amani
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Hesam Kamyab
- Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Jalan Sultan Yahya Petra, 54100, Kuala Lumpur, Malaysia
- Department of Biomaterials, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai 600077, India, Chennai, India
| | - Shreeshivadasan Chelliapan
- Engineering Department, Razak Faculty of Technology & Informatics, Universiti Teknologi Malaysia, Jalan Sultan Yahya Petra, 54100, Kuala Lumpur, Malaysia
| |
Collapse
|